Dr Farah Houdroge
Senior Research Officer
Working groups
Background
Dr Farah Houdroge is a Senior Research Officer in the Modelling and Biostatistics Group, specialising in infectious disease modelling and economic evaluation of public health interventions.
Her work focuses on hepatitis C elimination, harm reduction, and health system optimisation, combining dynamic transmission models with cost-effectiveness, cost-benefit, and allocative efficiency analyses to inform policy and investment decisions at national and international levels. Her outputs have directly informed Australia’s 2023–2030 National Blood Borne Virus and STI Strategies, and she has led economic analyses across more than 100 countries in collaboration with international partners including the World Bank, the Bill & Melinda Gates Foundation, and Janssen.
She holds a PhD in Computational Fluid Dynamics from Monash University (2018) and undergraduate and postgraduate degrees in Applied Mathematics from Université Paul Sabatier, Toulouse.
Qualifications
2027: DU in Health Economic Evaluation Methods and Practice (MPEME), ISPED, Université de Bordeaux, France
2018: PhD in Computational Fluid Dynamics, Monash University, Melbourne, Australia
2013: MSc in Fluid Dynamics Research, Paul Sabatier University, Toulouse, France
2011: BSc in Mathematics and Applications, Paul Sabatier University, Toulouse, France
Appointments
2026–current: Co-supervisor, PhD Candidate, Burnet Institute / Monash University
2025–current: Associate Investigator, Hepatitis C Modelling Advisory Committee, Australia Member, Vaccine Impact Modelling Consortium (VIMC)
Awards
2014–2017: Faculty of Engineering International Postgraduate Research Scholarship (FEIPRS)
2014–2017: Monash Departmental Stipend Scholarship (MDS)
Positions
2023–current: Senior Research Officer, Burnet Institute, Melbourne, Australia
2020–2023: Postdoctoral Research Fellow, Burnet Institute, Melbourne, Australia
2017–2020: Research Assistant and Teaching Associate, Monash University, Melbourne, Australia
Burnet publications
View 8 moreCost-benefit analysis of a potential hepatitis C vaccine: a modelling study
BMC Infectious Diseases
Farah Houdroge et al
HIGH Horizons - CARBOMICA tool
Zenodo (CERN European Organization for Nuclear Research)
Jetina Juliet Tsvaki et al
HIGH Horizons - CARBOMICA tool
Zenodo (CERN European Organization for Nuclear Research)
Jetina Juliet Tsvaki et al
News and features
Prison needle programs could save millions
Burnet research shows how prison needle and syringe programs could save treatment costs for hepatitis C and injection-related infections.
Prison needle programs could save double what they cost – our new modelling shows how
Australia leads the world in community-based needle and syringe programs. But they are not used in Australian prisons – which are hotspots for injection-related infections.